Cannabis Law Report

JULY 1, 2021

Clinical trials repeatedly demonstrate their promise for treating mood, anxiety, and substance use disorders. POPLAR is the first academic initiative focused on psychedelics law and policy, positioned to be a global leader for research and education in this space. Background. The Project.

Law 59

Law Policy Research and Development Clinical Trials 59

Project CBD

FEBRUARY 28, 2023

The following excerpt analyzes CBD marketing trends reported by the American Botanical Council, a membership organization that educates consumers, health care professionals, journalists, and others about the safe and effective use of medicinal plants. (E-commerce sales of CBD in the U.S. in 2021 reached $2 billion, according to Statistica.)

CBD 144

CBD Seed-To-Sale Food Access 144

SpeedWeed

JULY 6, 2021

The Project on Psychedelics Law and Regulation (POPLAR) is a three-year project aiming to “promote safety, innovation, and equity in psychedelics research, commerce, and therapeutics,” the university said in a press release.

Policy 52

Policy Law Research and Development Therapy 52

TheAnswerPage

JANUARY 11, 2022

As the Editor-in-Chief of the medical education website called TheAnswerPage.com for nearly two decades, I have assessed multiple educational gaps in the healthcare community. Thus, an educational gap developed, creating a less than ideal situation for medical marijuana patients. So, why did this educational gap develop?

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JULY 28, 2021

Cepharanthine is on its way to establishing itself as a once per day, oral anti-cancer therapeutic with a well-established safety profile which will pave the way for an expedited clinical development pathway and future partnering opportunities with pharmaceutical companies. ” Next Steps. ” Next Steps. dcohen@pharmadrug.co.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

MARCH 29, 2020

At an HIV Community Cannabis Education event held in Toronto, a cannabis company proudly declared their company had not had a single product recall to date. This post explores the manufacturing and research standards to consider when conducting research studies with cannabis. . . Product Quality in Manufacturing.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Healer

DECEMBER 17, 2021

The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. Adverse events reported for these participants were mild and included fatigue, diarrhea, and nausea. .

CBD 98

CBD THC Conditions Medicine 98

Healer

DECEMBER 17, 2021

The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. Adverse events reported for these participants were mild and included fatigue, diarrhea, and nausea. [7].

CBD 52

CBD THC Conditions Medicine 52

The Cannigma

DECEMBER 22, 2021

I think anyone that gets into this business is, we get addicted to this, to the smart event where we’re working around the clock, there’s always something new. We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Framings that more often carried a negative tone were related to poor evidence and safety issues.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 4, 2021

Through his social media outlets, podcast, blog, and interviews, Tim has educated hundreds of millions of people about psychedelics. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51